AbbVie seeks approval for upadacitinib to treat nr-axSpA

AbbVie seeks FDA and EMA approval for upadacitinib to treat non-radiographic axial spondyloarthritis. Credit: Hal Gatewood on Unsplash.



  • AbbVie